A Drug Utilization Study to Evaluate Indicators of Adherence to the Risk Minimization Measures for Ritlecitinib Using Electronic Healthcare Data in Denmark, France, and Sweden

First published 21/05/2025

Last updated 21/05/2025

EU PAS number:

EUPAS1000000523

Study

Planned

Documents

Study protocol

Initial protocol

B7981102_RITLECITINIB DUS PROTOCOL_V1.0_01MAR2024.pdf

English (335.03 KB - PDF)View document

Study results

Study report

Other information

ENCePP Seal

ENCePP Seal documents

Secondary tabs